Skip to main content

Advertisement

SpringerLink
Log in

The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Previous evidence indicate that genetic variants of X-ray repair cross-complementing group 1 gene (XRCC1) are potentially associated with the development of lung cancer. This study aimed to detect the relationship between the XRCC1 genetic variants and lung cancer susceptibility. A total of 420 lung cancer patients and 425 cancer-free healthy controls were recruited in this case–control study. The genotypes of XRCC1 genetic variants were investigated by the polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). The relationship between the XRCC1 genetic variants and lung cancer susceptibility was determined by the association analyses. We found that the distributions of allelic and genotypic in lung cancer patients were significantly different from those of cancer-free healthy controls. Our data indicated that the XRCC1 c.1161G>A and c.1779C>G genetic variants were significantly associated with the increased susceptibility to lung cancer [for c.1161G>A, AA versus (vs.) GG: odds ratio (OR) 2.59, 95 % confidence interval (95 % CI) 1.59–4.21, χ 2 = 15.17, P < 0.001; A vs. G: OR 1.39, 95 % CI 1.13–1.70, P = 0.002; for c.1779C>G, GG vs. CC: OR 2.51, 95 % CI 1.42–4.44, χ 2 = 10.60, P = 0.001; G vs. C: OR 1.24, 95 % CI 1.00–1.54, χ 2 = 3.98, P = 0.046]. The allele A and genotype AA of c.1161G>A and allele G and genotype GG of c.1779C>G genetic variants may enhance lung cancer susceptibility. Taken together, these findings show that the functional c.1161G>A and c.1779C>G genetic variants of XRCC1 are associated with lung cancer susceptibility in the Chinese Han populations and might be used as molecular markers for evaluating the risk of lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.

    Article  PubMed  Google Scholar 

  2. Cui Z, Yin Z, Li X, Wu W, Guan P, Zhou B. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis. BMC Cancer. 2012;12:71.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Yin Z, Zhou B, He Q, Li M, Guan P, Li X, Cui Z, Xue X, Su M, Ma R, Bai W, Xia S, Jiang Y, Xu S, Lv Y. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC Cancer. 2009;9:439.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  5. Yuan Z, Zeng X, Yang D, Wang W, Liu Z. Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk. PLoS ONE. 2013;8:e61047.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Guilbert JJ. The world health report 2002—reducing risks, promoting healthy life. Educ Health (Abingdon). 2003;16:230.

    Article  CAS  Google Scholar 

  7. Viktorsson K, De Petris L, Lewensohn R. The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun. 2005;331:868–80.

    Article  PubMed  CAS  Google Scholar 

  8. Karkucak M, Yakut T, Evrensel T, Deligonul A, Gulten T, Ocakoglu G, Kurt E, Kanat O, Cubukcu E, Sehitoglu I, Canhoroz M. XRCC1 gene polymorphisms and risk of lung cancer in Turkish patients. Int J Hum Genet. 2012;2:113–7.

    Google Scholar 

  9. Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.

    Article  PubMed  Google Scholar 

  10. Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol. 2008;134:645–52.

    Article  PubMed  CAS  Google Scholar 

  11. Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, Tardon A. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7:162.

    Article  PubMed  Google Scholar 

  12. Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, Selvaggi G, Gregori D, DeMarchi M, Scagliotti GV. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res. 2007;13:2876–81.

    Article  PubMed  CAS  Google Scholar 

  13. Chen J, Zhao QW, Shi GM, Wang LR. XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies. J Zhejiang Univ Sci B. 2012;13:875–83.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Guo S, Li X, Gao M, Li Y, Song B, Niu W. The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese. PLoS ONE. 2013;8:e56213.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  15. Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, Zhao Y, Zhou Y, Wang H, Chen X, Zhang L, Tan W, Wei Q, Lin D, He F. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene. 2006;25:3613–20.

    Article  PubMed  CAS  Google Scholar 

  16. Yin J, Vogel U, Ma Y, Qi R, Wang H. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women. Cancer Genet Cytogenet. 2009;188:26–31.

    Article  PubMed  CAS  Google Scholar 

  17. Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, Mavroudis D. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer. 2009;10:118–23.

    Article  PubMed  CAS  Google Scholar 

  18. Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry CP Jr, Seldin MF, Kelsey KT, Wiencke JK. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis. 2009;30:78–87.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Butkiewicz D, Rusin M, Sikora B, Lach A, Chorazy M. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep. 2011;38:5231–41.

    Article  PubMed  CAS  Google Scholar 

  20. Li Y, Huang XE, Jin GF, Shen HB, Xu L. Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. Asian Pac J Cancer Prev. 2011;12:739–42.

    PubMed  Google Scholar 

  21. Wang Y, Yang H, Li H, Li L, Wang H, Liu C, Zheng Y. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett. 2009;285:134–40.

    Article  PubMed  CAS  Google Scholar 

  22. Huang G, Cai S, Wang W, Zhang Q, Liu A. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies. PLoS ONE. 2013;8:e68457.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  23. Letkova L, Matakova T, Musak L, Sarlinova M, Krutakova M, Slovakova P, Kavcova E, Jakusova V, Janickova M, Drgova A, Berzinec P, Halasova E. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences. Mol Biol Rep. 2013;40:5261–73.

    Article  PubMed  CAS  Google Scholar 

  24. Li Y, Huang Y, Cao YS, Zeng J, Tong WN, Xu SL, Zhuo AS. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese. Tumour Biol. 2013;34:3681–5.

  25. Li W, Li K, Zhao L, Zou H. DNA repair pathway genes and lung cancer susceptibility: a meta-analysis. Gene. 2014;538:361–5.

  26. Rybarova S, Hodorova I, Muri J, Mihalik J, Adamkov M, Svajdler M, Piovarci D, Mirossay L. Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer. Tumori. 2011;97:79–85.

    PubMed  CAS  Google Scholar 

  27. Perez-Morales R, Mendez-Ramirez I, Castro-Hernandez C, Martinez-Ramirez OC, Gonsebatt ME, Rubio J. Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: application of the additive model for cancer. Genet Mol Biol. 2011;34:546–52.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  28. Natukula K, Jamil K, Pingali UR, Attili VS, Madireddy UR. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. Asian Pac J Cancer Prev. 2013;14:5275–9.

    Article  PubMed  Google Scholar 

  29. Sun Y, Zhang YJ, Kong XM. No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. Asian Pac J Cancer Prev. 2013;14:5171–4.

    Article  PubMed  Google Scholar 

  30. Guo QX, Yang WH, Zhai JF, Han FC, Wang CY. XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures. Tumour Biol. 2013;34:2989–94.

    Article  PubMed  CAS  Google Scholar 

  31. Ouyang FD, Yang FL, Chen HC, Khan MA, Huang FM, Wan XX, Xu AH, Huang X, Zhou MJ, Fang Q, Zhang DZ. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol. 2013;34:2843–8.

    Article  PubMed  CAS  Google Scholar 

  32. Wang JY, Cai Y. X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis. Tumour Biol. 2014;35:411–8.

  33. Wu T, Xu YH, Ye XL. X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Tumour Biol. 2013;34:2611–5.

    Article  PubMed  CAS  Google Scholar 

  34. Li D, Zhou Q, Liu Y, Yang Y, Li Q. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Med Oncol. 2012;29:1622–8.

    Article  PubMed  CAS  Google Scholar 

  35. Ke HG, Li J, Shen Y, You QS, Yan Y, Dong HX, Liu JH, Shen ZY. Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients. Asian Pac J Cancer Prev. 2012;13:4413–6.

    Article  PubMed  Google Scholar 

  36. Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep. 2012;39:9535–47.

    Article  PubMed  CAS  Google Scholar 

  37. Huang J, Zhang J, Zhao Y, Liao B, Liu J, Li L, Liao M, Wang L. The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Mol Biol Rep. 2011;38:4565–73.

    Article  PubMed  CAS  Google Scholar 

  38. Zhang J, Zeng XT, Lei JR, Tang YJ, Yang J. No association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis. Tumour Biol. 2014;35:5629–35.

  39. Wang R, Zhang Y, Zhang J, Zhi X. Association of X-ray repair cross-complementing group 1 promoter rs3213245 polymorphism with lung cancer risk. Tumour Biol. 2014;35:1739–43.

  40. Daly AK, Steen VM, Fairbrother KS, Idle JR. CYP2D6 multiallelism. Methods Enzymol. 1996;272:199–210.

    Article  PubMed  CAS  Google Scholar 

  41. Wang L, Chen Z, Wang Y, Chang D, Su L, Guo Y, Liu C. The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population. Tumour Biol. 2014;35:5389–93.

Download references

Conflict of interest

The authors declared that they have no conflict of interests.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Shenyang, 110004, Liaoning Province, People’s Republic of China

    Jun Tang & Jungang Zhao

  2. Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, People’s Republic of China

    Jianzhu Zhao

Authors
  1. Jun Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jianzhu Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jungang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jungang Zhao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, J., Zhao, J. & Zhao, J. The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population. Med Oncol 31, 157 (2014). https://doi.org/10.1007/s12032-014-0157-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-014-0157-7

Keywords

Search

Navigation